Cargando…
Distinct Role of CD11b(+)Ly6G(−)Ly6C(−) Myeloid-Derived Cells on the Progression of the Primary Tumor and Therapy-Associated Recurrent Brain Tumor
Myeloid-derived cells have been implicated as playing essential roles in cancer therapy, particularly in cancer immunotherapy. Most studies have focused on either CD11b(+)Ly6G(+)Ly6C(+) granulocytic or polymorphonuclear myeloid-derived suppressor cells (G-MDSCs or PMN-MDSCs) or CD11b(+)Ly6G(−)Ly6C(+...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016541/ https://www.ncbi.nlm.nih.gov/pubmed/31878276 http://dx.doi.org/10.3390/cells9010051 |